Pediatric Plaque Psoriasis (PsO) | COSENTYX® (secukinumab)

For people with plaque psoriasis (6+) or ERA (4+) or PsA (2+)

In a clinical trial, most children aged 6-18 years with severe plaque psoriasis taking COSENTYX 75 mg or 150 mg^† were clear or almost clear at 12 weeks.

For those taking 75 mg (less than 110 lbs):

32% were clear or almost clear
Approximately 6 out of 10 saw at least 75% skin clearance
Approximately 4 out of 10 saw at least 90% skin clearance

For those taking 150 mg (110 lbs or more):

81% were clear or almost clear
Approximately 9 out of 10 saw at least 75% skin clearance
Approximately 8 out of 10 saw at least 90% skin clearance

^†Dosage strength based on child's weight.

For more on treating psoriasis in children, download our brochure, Treating Kids and Teens With COSENTYX.

Download Brochure

How does COSENTYX work?

COSENTYX is a biologic treatment for plaque psoriasis in children and adults that works from the inside out. COSENTYX is designed to target and block IL-17A, which is believed to play a role in inflammation that causes the psoriasis plaques your child is seeing. Did you know an overactive immune system is like an overactive tennis ball machine? Watch this video to see how taking COSENTYX may help.

Watch Now

Patient portrayal of how COSENTYX works.

^‡Across all indications combined.

Lauralee3 — Individual results may vary. LauraLee was compensated for her time.

"I've had psoriasis since I was 16. Dealing with it as a teenager was hard, 'cuz kids can be so mean. I really wish COSENTYX had been around when I was younger."

Convenient once-a-month dosing^§

Your child's doctor will prescribe the dose of COSENTYX that's right for your child, guided by your child’s weight. To start, your child will take COSENTYX once a week for 5 weeks. Then, just once a month for maintenance. This can mean fewer interruptions in both your and your child's daily routines.

If your child weighs less than 110 lbs, the recommended dose of COSENTYX is 75 mg. If your child weighs more than 110 lbs, the recommended dose is 150 mg.

If the prescribed dose of COSENTYX is 75 mg, you must give 1 injection of the COSENTYX 75-mg prefilled syringe for each dose
If the prescribed dose of COSENTYX is 150 mg, you must give 1 injection of the COSENTYX 150-mg Sensoready^® Pen or 150-mg prefilled syringe for each dose

^§Monthly dose equals 1 dose every 4 weeks.

How to use the Prefilled Syringe

Watch How to Use the COSENTYX Prefilled Syringe (75 mg & 150 mg) to learn how to give a once-monthly injection, with helpful tips for parents and caregivers.

How to use the Sensoready Pen

Watch How to Use the COSENTYX Sensoready Pen (150 mg) to learn how to give a once-monthly injection, with helpful tips for parents and caregivers.

Get dedicated personal support and savings options for COSENTYX right from the start.

Sign up for COSENTYX^® Connect, a free, customized program for those considering or taking COSENTYX. You'll get services and support to help both you and your child—including injection resources, savings options like a $0 co-pay,* if eligible, and a dedicated COSENTYX^® Connect Team Member.

Learn More

Tap to see IMPORTANT SAFETY INFORMATION AND APPROVED USES

IMPORTANT SAFETY INFORMATION

Do not use COSENTYX if you have had a severe allergic reaction to secukinumab or any of the other ingredients in COSENTYX. See the Medication Guide for a complete list of ingredients.

What is the most important information I should know about COSENTYX?

COSENTYX is a medicine that affects your immune system. COSENTYX may increase your risk of having serious side effects such as…

Do not use COSENTYX if you have had a severe allergic reaction to secukinumab or any of the other ingredients in COSENTYX. See the Medication Guide for a complete list of ingredients.

What is the most important information I should know about COSENTYX?

COSENTYX is a medicine that affects your immune system. COSENTYX may increase your risk of having serious side effects such as:

Infections

COSENTYX may lower the ability of your immune system to fight infections and may increase your risk of infections. Some people have died from these infections.

Your doctor should check you for tuberculosis (TB) before starting treatment with COSENTYX.
If your doctor feels that you are at risk for TB, you may be treated with medicine for TB before you begin treatment with COSENTYX and during treatment with COSENTYX.
Your doctor should watch you closely for signs and symptoms of TB during treatment with COSENTYX. Do not use COSENTYX if you have an active TB infection.

Before starting COSENTYX, tell your doctor if you:

are being treated for an infection
have an infection that does not go away or that keeps coming back
have TB or have been in close contact with someone with TB
think you have an infection or have symptoms of an infection such as: fevers, sweats, or chills; muscle aches; cough; shortness of breath; blood in your phlegm; weight loss; warm, red, or painful skin or sores on your body; diarrhea or stomach pain; burning when you urinate or urinate more often than normal

After starting COSENTYX, call your doctor right away if you have any signs of infection listed above. Do not use COSENTYX if you have any signs of infection unless you are instructed to by your doctor.

What are the possible side effects of COSENTYX?

COSENTYX may cause serious side effects, including:

Serious allergic reactions

Serious allergic reactions can occur. Get emergency medical help right away if you get any of the following symptoms: feeling faint; swelling of your face, eyelids, lips, mouth, tongue, or throat; trouble breathing or throat tightness; chest tightness; skin rash or hives (red, itchy bumps).

If you have a severe allergic reaction, do not give another injection of COSENTYX.

Inflammatory bowel disease

New cases of inflammatory bowel disease or "flare-ups" can happen with COSENTYX, and can sometimes be serious. If you have inflammatory bowel disease (ulcerative colitis or Crohn's disease), tell your doctor if you have worsening disease symptoms during treatment with COSENTYX or develop new symptoms of stomach pain or diarrhea.

Severe skin reactions that look like eczema can happen during treatment with COSENTYX from days to months after your first dose and can sometimes lead to hospitalization. Your doctor may temporarily stop treatment with COSENTYX if you develop severe skin reactions. Tell your doctor if you have any of the following signs or symptoms: redness or rash; itching; small bumps or patches; your skin is dry or feels like leather; blisters on the hands or feet that ooze or become crusty or skin peeling.

The most common side effects of COSENTYX include: cold symptoms, diarrhea, and upper respiratory tract infections.

These are not all of the possible side effects of COSENTYX. Call your doctor for medical advice about side effects.

Before using COSENTYX, tell your doctor if you:

have any of the conditions or symptoms listed above for infections.
have inflammatory bowel disease (Crohn's disease or ulcerative colitis).
are allergic to latex. The needle cap on the COSENTYX Sensoready® pen, and 150 mg/mL and 75 mg/0.5 mL prefilled syringes contains latex.
have recently received or are scheduled to receive an immunization (vaccine). People who take COSENTYX should not receive live vaccines. Children should be brought up to date with all vaccines before starting COSENTYX.
have any other medical conditions and all the medicines you take, including prescription and over‑the‑counter medicines, vitamins, and herbal supplements. Keep a list of your medicines to show your healthcare provider and pharmacist when you get a new medicine.
are pregnant or plan to become pregnant. It is not known if COSENTYX can harm your unborn baby. You and your doctor should decide if you will use COSENTYX.
are breastfeeding or plan to breastfeed. It is not known if COSENTYX passes into your breast milk.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch ↗, or call 1-800-FDA-1088.

Please see full Prescribing Information, including Medication Guide.

10/23 308659

In a clinical trial, most children aged 6-18 years with severe plaque psoriasis taking COSENTYX 75 mg or 150 mg† were clear or almost clear at 12 weeks.